Weill Cornell Medicine has been awarded a five-year, $7.8 million grant from the National Heart, Lung, and Blood Institute to study whether the antibiotic doxycycline may slow the progression of emphysema in people living with well-controlled HIV.
Acinetobacter pittii (A. pittii), a type of bacteria, is evolving to become more resistant to antibiotics and is finding ways to survive in the harsh environment of the International Space Station, according to new research led by Weill Cornell Medicine scientists.
Cornell is creating unique opportunities for innovation in the rapidly evolving field of structural biology thanks to cutting-edge facilities and support for intercampus collaborations between Cornell's Ithaca campus and Weill Cornell Medicine.
Cole, M.D. ’94, is the assistant vice provost for information services and chief information officer at Weill Cornell Medicine. He will begin his new role Jan. 1, 2023.
A $20 million gift from Andrew H. ’71 and Ann R. Tisch will foster engagement and collaboration between Cornell Tech and Weill Cornell Medicine, catalyzing new discoveries at the intersection of health and technology.
A Medicare system that is meant to assess and incentivize health care quality with pay adjustments may not be working as intended, according to a study from researchers at Weill Cornell Medicine.
Changes in a single gene open the door for harmful gut bacteria to set off the inflammation that drives Crohn’s disease, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Researchers from Weill Cornell Medicine and colleagues found that two-dose vaccines still provide protection against lung disease in rhesus macaques a year after they had been vaccinated as infants.
A gene linked to autism spectrum disorders plays a critical role in early brain development and may shape the formation of nerve connections in the brain.
